Literature DB >> 9328171

Smad4 (homolog of human DPC4) and Smad2 (homolog of human JV18-1): candidates for murine lung tumor resistance and suppressor genes.

T R Devereux1, C H Anna, A C Patel, C M White, M F Festing, M You.   

Abstract

In this study we investigated the mouse mad-related genes, Smad4/Dpc4 and Smad2 (homolog of JV18-1), as candidates for involvement in lung tumor resistance and suppression. These genes are located in a region of mouse chromosome 18 that is syntenic with human 18q21.1, where several genes that are mutated in various cancers have been mapped. A newly identified murine lung tumor resistance locus, Par2 has also been mapped to this region of chromosome 18. We found no mutations in the coding regions of either gene in 11 lung tumors from B6CF1 (C57BL/6 x BALB/c) mice by RT-PCR and SSCP/RFLP, suggesting that these genes are not mutated in lung carcinogenesis in this strain. Moreover, loss of heterozygosity in this region of chromosome 18 was not detected in 28 lung adenocarcinomas from B6CF1 mice, 17 lung adenocarcinomas from B6C3F1 mice or 18 lung adenocarcinomas from AB6F1 mice. These data provide evidence that a 'classical' tumor suppressor gene for mouse lung carcinogenesis in these strains does not reside in this region. In order to investigate Smad4/Dpc4 and Smad2 as candidates for the Par2 resistance locus mapped to this region, we also sequenced the coding regions of both genes in cDNA from normal lungs of A/J, BALB/c and C57BL/6 inbred strains of mice. No polymorphisms were detected in the coding region of Smad4. In Smad2, two sequence polymorphisms were identified that are not in the conserved regions of the gene. Northern blot analysis revealed no differential expression in normal lung tissue among the three strains for either gene. Thus, in this study we found no evidence that either Smad4 or Smad2 represents the Par2 lung tumor resistance locus or is a lung tumor suppressor gene in the B6CF1 mice.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9328171     DOI: 10.1093/carcin/18.9.1751

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  4 in total

1.  Mutation and expression of the DCC gene in human lung cancer.

Authors:  T Kohno; T Sato; S Takakura; K Takei; K Inoue; M Nishioka; J Yokota
Journal:  Neoplasia       Date:  2000 Jul-Aug       Impact factor: 5.715

2.  Identification of candidate lung cancer susceptibility genes in mouse using oligonucleotide arrays.

Authors:  W J Lemon; H Bernert; H Sun; Y Wang; M You
Journal:  J Med Genet       Date:  2002-09       Impact factor: 6.318

3.  Epithelial and fibroblast cell lines derived from a spontaneous mammary carcinoma in a MMTV/neu transgenic mouse.

Authors:  Michael J Campbell; Wendy S Wollish; Margaret Lobo; Laura J Esserman
Journal:  In Vitro Cell Dev Biol Anim       Date:  2002-06       Impact factor: 2.416

4.  Alterations of the transforming growth factor-beta signaling pathway in hepatocellular carcinomas induced endogenously and exogenously in rats.

Authors:  Y Sasaki; T Tsujiuchi; N Murata; M Tsutsumi; Y Konishi
Journal:  Jpn J Cancer Res       Date:  2001-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.